ACEI與ARB臨床聯合應用防治糖尿病腎病_West China Medical Journal

Authors：

李燕 , 李雙慶

Corresponding?author：

Keywords：

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 李燕,李雙慶. ACEI與ARB臨床聯合應用防治糖尿病腎病. West China Medical Journal, 2008, 23(1): 181-182. doi: Copy

1.	Anderson S,Jung FF,Ingelfinger JR.Renal renin-angiotensin system in diabetes:functional,immunohistochemical,and molecular biological correlations[J].Am J Physiol,1993,265(4 Pt 2):F477-F486..
2.	Kikkawa R,Kitamura E,Fujiwara Y,et al.Biphasic alteration of renin-angiotensin-aldosterone system in streptozotocin-diabetic rats[J].Ren Physiol,1986,9(3):187-92..
3.	Touyz RM.Molecular and cellular mechanisms in vascular injury in hypertension:role of angiotensin Ⅱ[J].Curr Opin Nephrol Hypertens,2005,14(2):125-131..
4.	Wolf G,Ziyadeh FN.The role of angiotensin Ⅱ in diabetic nephropathy:emphasis on nonhemodynamic mechanisms[J].Am J Kidney Dis,1997,29(1):153-163..
5.	Leehey DJ,Singh AK,Alavi N,et al.Role of angiotensin Ⅱ in diabetic nephropathy[J].Kidney Int Suppl,2000,77:S93-S98..
6.	Wolf G,Haberstroh U,Neilson EG.Angiotensin Ⅱ stimulates the proliferation and biosynthesis of type Ⅰ collagen in cultured murine mesangial cells[J].Am J Pathol,1992,140(1):95-107..
7.	Huang XR,Chen WY,Truong LD,et al.Chymase is upregulated in diabetic nephropathy:implications for an alternative pathway of angiotensin Ⅱ-mediated diabetic renal and vascular disease[J].J Am Soc Nephrol,2003,14(7):1738-1747;Comment in:1952-1954..
8.	Mogensen CE,Neldam S,Tikkanen I,et al.Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension，microalbuminuria,and non-insulin dependent diabetes:the candesartan andlisinopril microalbuminuria(CALM)study.BMJ,2000,321:1440-1444..
9.	Cao Z,Bonnet F,Candido R,et al.Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury[J].J Am Soc Nephrol,2002,13(7):1773-1787..
10.	Komine N,Khang S,Wead LM,et al.Effect of combining an ACE inhibitor and an angiotensin Ⅱ receptor blocker on plasma and kidney tissue angiotensin Ⅱ levels[J].Am J Kidney Dis,2002,39(1):159-164..
11.	Tütüncü NB,Gürlek A,Gedik O.Efficacy of ACE inhibitors and ATⅡ receptor blockers in patients with microalbuminuria:a prospective study[J].Acta Diabetol,2001，38:157-161..
12.	Nakao N,Yoshimura A,Morita H,et al.Combination treatment of angiotensin-Ⅱ receptor blocker and angiotensin-converting-enzyme in Ahibitor in non-diabetic renal disease(COOPERATE):a randomised controlled trial[J].Lancet,2003,361:117-124..
13.	Teo K,Yusuf S.Rationale,design,and baseline characteristics of 2 large,simple,randomized trials evaluating telmisartan,ramipril,andtheir combination in high-risk patients:The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials[J].Am Heart J,2004,148(1):52-61..

1. Anderson S,Jung FF,Ingelfinger JR.Renal renin-angiotensin system in diabetes:functional,immunohistochemical,and molecular biological correlations[J].Am J Physiol,1993,265(4 Pt 2):F477-F486..
2. Kikkawa R,Kitamura E,Fujiwara Y,et al.Biphasic alteration of renin-angiotensin-aldosterone system in streptozotocin-diabetic rats[J].Ren Physiol,1986,9(3):187-92..
3. Touyz RM.Molecular and cellular mechanisms in vascular injury in hypertension:role of angiotensin Ⅱ[J].Curr Opin Nephrol Hypertens,2005,14(2):125-131..
4. Wolf G,Ziyadeh FN.The role of angiotensin Ⅱ in diabetic nephropathy:emphasis on nonhemodynamic mechanisms[J].Am J Kidney Dis,1997,29(1):153-163..
5. Leehey DJ,Singh AK,Alavi N,et al.Role of angiotensin Ⅱ in diabetic nephropathy[J].Kidney Int Suppl,2000,77:S93-S98..
6. Wolf G,Haberstroh U,Neilson EG.Angiotensin Ⅱ stimulates the proliferation and biosynthesis of type Ⅰ collagen in cultured murine mesangial cells[J].Am J Pathol,1992,140(1):95-107..
7. Huang XR,Chen WY,Truong LD,et al.Chymase is upregulated in diabetic nephropathy:implications for an alternative pathway of angiotensin Ⅱ-mediated diabetic renal and vascular disease[J].J Am Soc Nephrol,2003,14(7):1738-1747;Comment in:1952-1954..
8. Mogensen CE,Neldam S,Tikkanen I,et al.Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension，microalbuminuria,and non-insulin dependent diabetes:the candesartan andlisinopril microalbuminuria(CALM)study.BMJ,2000,321:1440-1444..
9. Cao Z,Bonnet F,Candido R,et al.Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury[J].J Am Soc Nephrol,2002,13(7):1773-1787..
10. Komine N,Khang S,Wead LM,et al.Effect of combining an ACE inhibitor and an angiotensin Ⅱ receptor blocker on plasma and kidney tissue angiotensin Ⅱ levels[J].Am J Kidney Dis,2002,39(1):159-164..
11. Tütüncü NB,Gürlek A,Gedik O.Efficacy of ACE inhibitors and ATⅡ receptor blockers in patients with microalbuminuria:a prospective study[J].Acta Diabetol,2001，38:157-161..
12. Nakao N,Yoshimura A,Morita H,et al.Combination treatment of angiotensin-Ⅱ receptor blocker and angiotensin-converting-enzyme in Ahibitor in non-diabetic renal disease(COOPERATE):a randomised controlled trial[J].Lancet,2003,361:117-124..
13. Teo K,Yusuf S.Rationale,design,and baseline characteristics of 2 large,simple,randomized trials evaluating telmisartan,ramipril,andtheir combination in high-risk patients:The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials[J].Am Heart J,2004,148(1):52-61..

West China Medical Journal

ACEI與ARB臨床聯合應用防治糖尿病腎病

Abstract Full text Figures/Tables Video References Cited by

Format

Content